Lantheus Medical Imaging
Private Company
Total funding raised: $65M
Overview
Lantheus Medical Imaging is a leading public radiopharmaceutical company with a mission to 'Find, Fight, and Follow' disease through targeted diagnostic and therapeutic innovations. The company has achieved significant commercial success with products like PYLARIFY for prostate cancer imaging and is aggressively expanding its pipeline through strategic acquisitions and internal R&D into high-growth areas like radiotherapeutics and neurology diagnostics. Its strategy hinges on vertical integration, managing complex radiopharmaceutical logistics, and capitalizing on the growing precision medicine paradigm in nuclear medicine.
Technology Platform
An integrated radiopharmaceutical platform encompassing target/ligand discovery, radiochemistry, manufacturing, quality control, and global logistics for diagnostic and therapeutic isotopes.